

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 9.55423452 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 9.55423452 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 8.33791860 |
| 4 | keratinization (GO:0031424) | 7.78255088 |
| 5 | peptide cross-linking (GO:0018149) | 7.42416219 |
| 6 | cilium or flagellum-dependent cell motility (GO:0001539) | 6.54263251 |
| 7 | axonemal dynein complex assembly (GO:0070286) | 6.50981883 |
| 8 | keratinocyte differentiation (GO:0030216) | 6.38608671 |
| 9 | response to type I interferon (GO:0034340) | 6.36620644 |
| 10 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 6.36432044 |
| 11 | type I interferon signaling pathway (GO:0060337) | 6.29604662 |
| 12 | cellular response to type I interferon (GO:0071357) | 6.29604662 |
| 13 | desmosome organization (GO:0002934) | 6.23771589 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.99140213 |
| 15 | cilium movement (GO:0003341) | 5.80611378 |
| 16 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 5.75340010 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.68090766 |
| 18 | epithelial cilium movement (GO:0003351) | 5.54525090 |
| 19 | axoneme assembly (GO:0035082) | 5.39889334 |
| 20 | transepithelial transport (GO:0070633) | 5.10265988 |
| 21 | response to interferon-alpha (GO:0035455) | 5.06651525 |
| 22 | keratinocyte development (GO:0003334) | 4.92771750 |
| 23 | epidermal cell differentiation (GO:0009913) | 4.91158842 |
| 24 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 4.87047514 |
| 25 | fucose catabolic process (GO:0019317) | 4.78314741 |
| 26 | L-fucose metabolic process (GO:0042354) | 4.78314741 |
| 27 | L-fucose catabolic process (GO:0042355) | 4.78314741 |
| 28 | regulation of cilium movement (GO:0003352) | 4.72773204 |
| 29 | establishment of skin barrier (GO:0061436) | 4.63279480 |
| 30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.51023365 |
| 31 | cellular response to interferon-beta (GO:0035458) | 4.50167600 |
| 32 | establishment of tissue polarity (GO:0007164) | 4.40878511 |
| 33 | establishment of planar polarity (GO:0001736) | 4.40878511 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 4.36463658 |
| 35 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.35578938 |
| 36 | response to interferon-beta (GO:0035456) | 4.30803492 |
| 37 | positive regulation of interferon-alpha production (GO:0032727) | 4.30682070 |
| 38 | tolerance induction (GO:0002507) | 4.27125843 |
| 39 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.23945730 |
| 40 | T cell migration (GO:0072678) | 4.14396217 |
| 41 | regulation of interferon-alpha production (GO:0032647) | 4.07182708 |
| 42 | negative T cell selection (GO:0043383) | 4.05939476 |
| 43 | motile cilium assembly (GO:0044458) | 4.05010371 |
| 44 | primary alcohol catabolic process (GO:0034310) | 4.01974210 |
| 45 | response to interleukin-15 (GO:0070672) | 4.01829548 |
| 46 | keratinocyte proliferation (GO:0043616) | 3.99118475 |
| 47 | regulation of response to interferon-gamma (GO:0060330) | 3.98986618 |
| 48 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.98542656 |
| 49 | lateral sprouting from an epithelium (GO:0060601) | 3.91195545 |
| 50 | cellular response to interferon-alpha (GO:0035457) | 3.90309324 |
| 51 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.88109114 |
| 52 | negative thymic T cell selection (GO:0045060) | 3.86227345 |
| 53 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.85715195 |
| 54 | cellular response to interleukin-15 (GO:0071350) | 3.80825333 |
| 55 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.80242377 |
| 56 | negative regulation of viral genome replication (GO:0045071) | 3.76484864 |
| 57 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.70368149 |
| 58 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.68655021 |
| 59 | retinoic acid metabolic process (GO:0042573) | 3.64863103 |
| 60 | regulation of water loss via skin (GO:0033561) | 3.62105581 |
| 61 | regulation of RIG-I signaling pathway (GO:0039535) | 3.57813212 |
| 62 | epidermis development (GO:0008544) | 3.57538595 |
| 63 | molting cycle (GO:0042303) | 3.56426022 |
| 64 | hair cycle (GO:0042633) | 3.56426022 |
| 65 | positive thymic T cell selection (GO:0045059) | 3.54782252 |
| 66 | interferon-gamma production (GO:0032609) | 3.52664487 |
| 67 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.51990008 |
| 68 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.46196105 |
| 69 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.38965212 |
| 70 | positive regulation of humoral immune response (GO:0002922) | 3.38785366 |
| 71 | JAK-STAT cascade (GO:0007259) | 3.35148324 |
| 72 | cornea development in camera-type eye (GO:0061303) | 3.31462001 |
| 73 | * cellular response to interferon-gamma (GO:0071346) | 3.30258402 |
| 74 | defense response to virus (GO:0051607) | 3.29652373 |
| 75 | cellular response to exogenous dsRNA (GO:0071360) | 3.29134348 |
| 76 | positive T cell selection (GO:0043368) | 3.28075601 |
| 77 | regulation of regulatory T cell differentiation (GO:0045589) | 3.27085526 |
| 78 | positive regulation by symbiont of host defense response (GO:0052509) | 3.26517224 |
| 79 | modulation by symbiont of host defense response (GO:0052031) | 3.26517224 |
| 80 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.26517224 |
| 81 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.26517224 |
| 82 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.26517224 |
| 83 | modulation by symbiont of host immune response (GO:0052553) | 3.26517224 |
| 84 | negative regulation of cell killing (GO:0031342) | 3.24657092 |
| 85 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.24657092 |
| 86 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.20440752 |
| 87 | cellular response to virus (GO:0098586) | 3.18669861 |
| 88 | cilium organization (GO:0044782) | 3.18596365 |
| 89 | regulation of memory T cell differentiation (GO:0043380) | 3.18070199 |
| 90 | T cell selection (GO:0045058) | 3.17896429 |
| 91 | multicellular organismal water homeostasis (GO:0050891) | 3.15599502 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.15261120 |
| 93 | thymic T cell selection (GO:0045061) | 3.12704557 |
| 94 | NIK/NF-kappaB signaling (GO:0038061) | 3.09655978 |
| 95 | regulation of T cell tolerance induction (GO:0002664) | 3.09339006 |
| 96 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09165968 |
| 97 | neural tube formation (GO:0001841) | 3.08734808 |
| 98 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.08187958 |
| 99 | piRNA metabolic process (GO:0034587) | 3.07386684 |
| 100 | positive regulation of interferon-beta production (GO:0032728) | 3.07173541 |
| 101 | exogenous drug catabolic process (GO:0042738) | 3.07011731 |
| 102 | fucosylation (GO:0036065) | 3.06368537 |
| 103 | immunoglobulin mediated immune response (GO:0016064) | 3.06149069 |
| 104 | ectoderm development (GO:0007398) | 3.04470462 |
| 105 | adaptation of signaling pathway (GO:0023058) | 3.04170189 |
| 106 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.03405825 |
| 107 | cilium assembly (GO:0042384) | 3.03191860 |
| 108 | growth hormone receptor signaling pathway (GO:0060396) | 3.02441541 |
| 109 | defense response to protozoan (GO:0042832) | 3.01796960 |
| 110 | negative regulation of telomere maintenance (GO:0032205) | 3.01555321 |
| 111 | thyroid hormone generation (GO:0006590) | 2.99010383 |
| 112 | regulation of microtubule-based movement (GO:0060632) | 2.97513664 |
| 113 | centriole replication (GO:0007099) | 2.97100130 |
| 114 | DNA deamination (GO:0045006) | 2.97012065 |
| 115 | platelet dense granule organization (GO:0060155) | 2.96906230 |
| 116 | leukocyte aggregation (GO:0070486) | 2.95287572 |
| 117 | regulation of natural killer cell differentiation (GO:0032823) | 2.93674250 |
| 118 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.92948860 |
| 119 | regulation of ruffle assembly (GO:1900027) | 2.92041209 |
| 120 | positive regulation of B cell mediated immunity (GO:0002714) | 2.91889828 |
| 121 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.91889828 |
| 122 | one-carbon compound transport (GO:0019755) | 2.91703945 |
| 123 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.91393106 |
| 124 | thyroid hormone metabolic process (GO:0042403) | 2.91315445 |
| 125 | protein localization to cilium (GO:0061512) | 2.90355979 |
| 126 | water homeostasis (GO:0030104) | 2.90015232 |
| 127 | cilium morphogenesis (GO:0060271) | 2.89619790 |
| 128 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.89333548 |
| 129 | * response to interferon-gamma (GO:0034341) | 2.87594322 |
| 130 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.87347302 |
| 131 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87095136 |
| 132 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.87012525 |
| 133 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.86852504 |
| 134 | response to protozoan (GO:0001562) | 2.86129390 |
| 135 | detection of light stimulus involved in visual perception (GO:0050908) | 2.85665989 |
| 136 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.85665989 |
| 137 | diterpenoid biosynthetic process (GO:0016102) | 2.85535067 |
| 138 | T cell costimulation (GO:0031295) | 2.83138864 |
| 139 | T-helper 1 type immune response (GO:0042088) | 2.80868285 |
| 140 | retinol metabolic process (GO:0042572) | 2.80363424 |
| 141 | lymphocyte costimulation (GO:0031294) | 2.78862658 |
| 142 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.78535414 |
| 143 | myeloid dendritic cell differentiation (GO:0043011) | 2.78138605 |
| 144 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.77538915 |
| 145 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.77476638 |
| 146 | alpha-beta T cell activation (GO:0046631) | 2.75220443 |
| 147 | ethanol metabolic process (GO:0006067) | 2.75175352 |
| 148 | hemidesmosome assembly (GO:0031581) | 2.74102884 |
| 149 | microtubule bundle formation (GO:0001578) | 2.71015136 |
| 150 | positive regulation of isotype switching (GO:0045830) | 2.70897841 |
| 151 | T cell receptor signaling pathway (GO:0050852) | 2.70497636 |
| 152 | regulation of germinal center formation (GO:0002634) | 2.69728888 |
| 153 | hair follicle morphogenesis (GO:0031069) | 2.69523316 |
| 154 | positive regulation of response to cytokine stimulus (GO:0060760) | 2.69439930 |
| 155 | drug catabolic process (GO:0042737) | 2.67762127 |
| 156 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.67568017 |
| 157 | left/right axis specification (GO:0070986) | 2.67137986 |
| 158 | macrophage activation involved in immune response (GO:0002281) | 2.66756618 |
| 159 | myeloid dendritic cell activation (GO:0001773) | 2.66581765 |
| 160 | protein polyglutamylation (GO:0018095) | 2.66427521 |
| 161 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.65768943 |
| 162 | multicellular organism reproduction (GO:0032504) | 2.65536120 |
| 163 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.65458608 |
| 164 | GPI anchor metabolic process (GO:0006505) | 2.65230207 |
| 165 | regulation of chemokine biosynthetic process (GO:0045073) | 2.65113035 |
| 166 | negative regulation of type I interferon production (GO:0032480) | 2.64711260 |
| 167 | negative regulation of neurological system process (GO:0031645) | 2.63712996 |
| 168 | response to xenobiotic stimulus (GO:0009410) | 2.63627705 |
| 169 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.63543961 |
| 170 | photoreceptor cell maintenance (GO:0045494) | 2.62946620 |
| 171 | negative regulation of acute inflammatory response (GO:0002674) | 2.62055668 |
| 172 | alpha-beta T cell differentiation (GO:0046632) | 2.61824742 |
| 173 | regulation of cytokine-mediated signaling pathway (GO:0001959) | 2.61556844 |
| 174 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.60843261 |
| 175 | response to host immune response (GO:0052572) | 2.60843261 |
| 176 | terpenoid biosynthetic process (GO:0016114) | 2.60400989 |
| 177 | positive regulation of response to biotic stimulus (GO:0002833) | 2.60281062 |
| 178 | B cell mediated immunity (GO:0019724) | 2.59399402 |
| 179 | respiratory chain complex IV assembly (GO:0008535) | 2.59271241 |
| 180 | positive regulation of defense response to virus by host (GO:0002230) | 2.58987427 |
| 181 | regulation of keratinocyte proliferation (GO:0010837) | 2.58582925 |
| 182 | behavioral response to nicotine (GO:0035095) | 2.56478476 |
| 183 | centriole assembly (GO:0098534) | 2.56355592 |
| 184 | kynurenine metabolic process (GO:0070189) | 2.53232563 |
| 185 | cytidine deamination (GO:0009972) | 2.52545566 |
| 186 | cytidine metabolic process (GO:0046087) | 2.52545566 |
| 187 | cytidine catabolic process (GO:0006216) | 2.52545566 |
| 188 | nucleotide transmembrane transport (GO:1901679) | 2.49522018 |
| 189 | protein K11-linked deubiquitination (GO:0035871) | 2.48251721 |
| 190 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.48223429 |
| 191 | cellular ketone body metabolic process (GO:0046950) | 2.48172747 |
| 192 | DNA methylation involved in gamete generation (GO:0043046) | 2.46924189 |
| 193 | intraciliary transport (GO:0042073) | 2.44008978 |
| 194 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.43861587 |
| 195 | magnesium ion transport (GO:0015693) | 2.42494035 |
| 196 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.41763390 |
| 197 | phenylpropanoid metabolic process (GO:0009698) | 2.40972329 |
| 198 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.40522084 |
| 199 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.37602742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.40920541 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.70662555 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.97324432 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.94540618 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.78994892 |
| 6 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.61439949 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.02865989 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 3.90696349 |
| 9 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.18630630 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.18309016 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.09751224 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.01336847 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72155948 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.70866572 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61764870 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.53750474 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42945186 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42441747 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.33894788 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.25274552 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.23607076 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.22365694 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.21715799 |
| 24 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.17892828 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.17565854 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.12810680 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.05603227 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.04089289 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.99058488 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97095609 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.95142609 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.90474235 |
| 33 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.88618883 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.87100417 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.86190992 |
| 36 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.85660154 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77364742 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.74498570 |
| 39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74408535 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.73976943 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.73066466 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.69214540 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68925094 |
| 44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.67434296 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67407398 |
| 46 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.62465705 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61322596 |
| 48 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.59918612 |
| 49 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.59241820 |
| 50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.58579151 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.57974755 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56865757 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.56836705 |
| 54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.56252508 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55273685 |
| 56 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54582001 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.52379014 |
| 58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51320160 |
| 59 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.50901588 |
| 60 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.48593756 |
| 61 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 1.48063395 |
| 62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47801738 |
| 63 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 1.47759686 |
| 64 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.47191835 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.46522193 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.43684079 |
| 67 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.43481675 |
| 68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.42779373 |
| 69 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.42767627 |
| 70 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.42767627 |
| 71 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.42519793 |
| 72 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.38792055 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38462615 |
| 74 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.37745450 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37640212 |
| 76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.36662389 |
| 77 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35914304 |
| 78 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35096255 |
| 79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.34893281 |
| 80 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.34142151 |
| 81 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.33307089 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.31712362 |
| 83 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.31228263 |
| 84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31071641 |
| 85 | MAF_26560356_Chip-Seq_TH2_Human | 1.29837638 |
| 86 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29525745 |
| 87 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.29051323 |
| 88 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28522025 |
| 89 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.27702798 |
| 90 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.27274095 |
| 91 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25717737 |
| 92 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.24853965 |
| 93 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24853965 |
| 94 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.24495394 |
| 95 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24017646 |
| 96 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.23958407 |
| 97 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.23294108 |
| 98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23064449 |
| 99 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.22956927 |
| 100 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.22956927 |
| 101 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.22569598 |
| 102 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22153526 |
| 103 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.22110633 |
| 104 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.21629188 |
| 105 | NCOR_22424771_ChIP-Seq_293T_Human | 1.21528856 |
| 106 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20000843 |
| 107 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19912808 |
| 108 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19431874 |
| 109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19271122 |
| 110 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18793235 |
| 111 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18458590 |
| 112 | MYC_22102868_ChIP-Seq_BL_Human | 1.17995137 |
| 113 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17560166 |
| 114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17155430 |
| 115 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17154969 |
| 116 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17048311 |
| 117 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.16877649 |
| 118 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.16351836 |
| 119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15411032 |
| 120 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15320973 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15033603 |
| 122 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.15017881 |
| 123 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14985871 |
| 124 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14615273 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14517350 |
| 126 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14276572 |
| 127 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13336005 |
| 128 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13317457 |
| 129 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13023609 |
| 130 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.12957792 |
| 131 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12795510 |
| 132 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.12301438 |
| 133 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12045152 |
| 134 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11578827 |
| 135 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11430338 |
| 136 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11299051 |
| 137 | * NFYB_21822215_ChIP-Seq_K562_Human | 1.11294560 |
| 138 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11144798 |
| 139 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10708441 |
| 140 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09726797 |
| 141 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.09408331 |
| 142 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09401251 |
| 143 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07585269 |
| 144 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07463912 |
| 145 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.05945706 |
| 146 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05809402 |
| 147 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05470336 |
| 148 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05179975 |
| 149 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05168415 |
| 150 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04851995 |
| 151 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03019718 |
| 152 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02494821 |
| 153 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02417585 |
| 154 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02322948 |
| 155 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01405956 |
| 156 | TBL1_22424771_ChIP-Seq_293T_Human | 1.00449446 |
| 157 | * NFYA_21822215_ChIP-Seq_K562_Human | 1.00053278 |
| 158 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99205614 |
| 159 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98614763 |
| 160 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97729494 |
| 161 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97560222 |
| 162 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95193763 |
| 163 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94337838 |
| 164 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93355905 |
| 165 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92644210 |
| 166 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90830566 |
| 167 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89770143 |
| 168 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89594567 |
| 169 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85343926 |
| 170 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84307859 |
| 171 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83249531 |
| 172 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82092691 |
| 173 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80969622 |
| 174 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.80751861 |
| 175 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80230618 |
| 176 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.76393487 |
| 177 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75493234 |
| 178 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74652524 |
| 179 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74570956 |
| 180 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72746963 |
| 181 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72239264 |
| 182 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71661675 |
| 183 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71578187 |
| 184 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.69808661 |
| 185 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69444691 |
| 186 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68953558 |
| 187 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68450091 |
| 188 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.68081545 |
| 189 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.67533935 |
| 190 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.61872186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 6.23603821 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 5.94485980 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.67874729 |
| 4 | MP0009785_altered_susceptibility_to | 3.96630995 |
| 5 | MP0002796_impaired_skin_barrier | 3.93829994 |
| 6 | MP0003724_increased_susceptibility_to | 3.47006663 |
| 7 | MP0010678_abnormal_skin_adnexa | 3.44348670 |
| 8 | MP0000685_abnormal_immune_system | 3.40224640 |
| 9 | MP0005671_abnormal_response_to | 3.37311136 |
| 10 | MP0000467_abnormal_esophagus_morphology | 3.36121401 |
| 11 | MP0004885_abnormal_endolymph | 3.00817905 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.98688181 |
| 13 | MP0000579_abnormal_nail_morphology | 2.93202681 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.90086443 |
| 15 | MP0005025_abnormal_response_to | 2.88308394 |
| 16 | MP0005387_immune_system_phenotype | 2.84342354 |
| 17 | MP0001790_abnormal_immune_system | 2.84342354 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.78909432 |
| 19 | MP0004510_myositis | 2.72985886 |
| 20 | MP0003878_abnormal_ear_physiology | 2.68289161 |
| 21 | MP0005377_hearing/vestibular/ear_phenot | 2.68289161 |
| 22 | MP0006082_CNS_inflammation | 2.63873722 |
| 23 | MP0002006_tumorigenesis | 2.61490855 |
| 24 | MP0003436_decreased_susceptibility_to | 2.60474150 |
| 25 | MP0001800_abnormal_humoral_immune | 2.59803911 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.59219027 |
| 27 | MP0000427_abnormal_hair_cycle | 2.44615329 |
| 28 | MP0002723_abnormal_immune_serum | 2.42610624 |
| 29 | MP0002234_abnormal_pharynx_morphology | 2.40113606 |
| 30 | MP0002452_abnormal_antigen_presenting | 2.29547563 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 2.26520934 |
| 32 | MP0001819_abnormal_immune_cell | 2.18209200 |
| 33 | MP0000566_synostosis | 2.18106757 |
| 34 | MP0002419_abnormal_innate_immunity | 2.17839278 |
| 35 | MP0002420_abnormal_adaptive_immunity | 2.16379573 |
| 36 | MP0002254_reproductive_system_inflammat | 2.15862329 |
| 37 | MP0001853_heart_inflammation | 2.06740081 |
| 38 | MP0002095_abnormal_skin_pigmentation | 2.06349084 |
| 39 | MP0004947_skin_inflammation | 2.06348929 |
| 40 | MP0005501_abnormal_skin_physiology | 2.01562542 |
| 41 | MP0000762_abnormal_tongue_morphology | 1.99243249 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.90810821 |
| 43 | MP0003303_peritoneal_inflammation | 1.86981578 |
| 44 | MP0002398_abnormal_bone_marrow | 1.86271772 |
| 45 | MP0003195_calcinosis | 1.85686957 |
| 46 | MP0001216_abnormal_epidermal_layer | 1.85281045 |
| 47 | MP0002653_abnormal_ependyma_morphology | 1.85137005 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.84046589 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.79982777 |
| 50 | MP0008877_abnormal_DNA_methylation | 1.79190393 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.78749402 |
| 52 | MP0002405_respiratory_system_inflammati | 1.76619120 |
| 53 | MP0000716_abnormal_immune_system | 1.76119533 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.73764774 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.67554851 |
| 56 | MP0008469_abnormal_protein_level | 1.67274067 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.65785855 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.64391893 |
| 59 | MP0003045_fibrosis | 1.63323121 |
| 60 | MP0009764_decreased_sensitivity_to | 1.61750313 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.58151334 |
| 62 | MP0008872_abnormal_physiological_respon | 1.55686075 |
| 63 | MP0003448_altered_tumor_morphology | 1.55536998 |
| 64 | MP0002098_abnormal_vibrissa_morphology | 1.55280904 |
| 65 | MP0001873_stomach_inflammation | 1.47046521 |
| 66 | MP0008789_abnormal_olfactory_epithelium | 1.45548780 |
| 67 | MP0010771_integument_phenotype | 1.45120009 |
| 68 | MP0002722_abnormal_immune_system | 1.44503049 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.42457276 |
| 70 | MP0002102_abnormal_ear_morphology | 1.42371866 |
| 71 | MP0002429_abnormal_blood_cell | 1.40997954 |
| 72 | MP0009780_abnormal_chondrocyte_physiolo | 1.33660171 |
| 73 | MP0002837_dystrophic_cardiac_calcinosis | 1.33498168 |
| 74 | MP0000343_altered_response_to | 1.33166754 |
| 75 | MP0001765_abnormal_ion_homeostasis | 1.32911077 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.31862669 |
| 77 | MP0000703_abnormal_thymus_morphology | 1.30812481 |
| 78 | MP0001984_abnormal_olfaction | 1.26730394 |
| 79 | MP0005310_abnormal_salivary_gland | 1.25995207 |
| 80 | MP0005360_urolithiasis | 1.24905501 |
| 81 | MP0004133_heterotaxia | 1.24409570 |
| 82 | MP0009053_abnormal_anal_canal | 1.24372006 |
| 83 | MP0002396_abnormal_hematopoietic_system | 1.24192611 |
| 84 | MP0001485_abnormal_pinna_reflex | 1.21846413 |
| 85 | MP0009278_abnormal_bone_marrow | 1.20920324 |
| 86 | MP0005551_abnormal_eye_electrophysiolog | 1.20371855 |
| 87 | MP0000371_diluted_coat_color | 1.18823100 |
| 88 | MP0001501_abnormal_sleep_pattern | 1.16297585 |
| 89 | MP0003011_delayed_dark_adaptation | 1.15002066 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 1.14877631 |
| 91 | MP0000470_abnormal_stomach_morphology | 1.14356972 |
| 92 | MP0004130_abnormal_muscle_cell | 1.14308174 |
| 93 | MP0000377_abnormal_hair_follicle | 1.14250089 |
| 94 | MP0001851_eye_inflammation | 1.14181024 |
| 95 | MP0009763_increased_sensitivity_to | 1.12661807 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 1.12281732 |
| 97 | MP0005253_abnormal_eye_physiology | 1.10664446 |
| 98 | MP0001545_abnormal_hematopoietic_system | 1.10635088 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 1.10635088 |
| 100 | MP0005365_abnormal_bile_salt | 1.09422065 |
| 101 | MP0003866_abnormal_defecation | 1.09171687 |
| 102 | MP0009840_abnormal_foam_cell | 1.07142288 |
| 103 | MP0000609_abnormal_liver_physiology | 1.06318561 |
| 104 | MP0003453_abnormal_keratinocyte_physiol | 1.05754475 |
| 105 | MP0005670_abnormal_white_adipose | 1.01914132 |
| 106 | MP0003828_pulmonary_edema | 1.01158254 |
| 107 | MP0002277_abnormal_respiratory_mucosa | 1.00754348 |
| 108 | MP0000858_altered_metastatic_potential | 1.00120464 |
| 109 | MP0004381_abnormal_hair_follicle | 0.99833740 |
| 110 | MP0000613_abnormal_salivary_gland | 0.98859707 |
| 111 | MP0005083_abnormal_biliary_tract | 0.98052873 |
| 112 | MP0002933_joint_inflammation | 0.97271943 |
| 113 | MP0005275_abnormal_skin_tensile | 0.94277434 |
| 114 | MP0001968_abnormal_touch/_nociception | 0.93723606 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.93500069 |
| 116 | MP0003646_muscle_fatigue | 0.92007996 |
| 117 | MP0002139_abnormal_hepatobiliary_system | 0.91912093 |
| 118 | MP0003787_abnormal_imprinting | 0.91190071 |
| 119 | MP0004019_abnormal_vitamin_homeostasis | 0.91104145 |
| 120 | MP0005023_abnormal_wound_healing | 0.89685600 |
| 121 | MP0006072_abnormal_retinal_apoptosis | 0.88181683 |
| 122 | MP0005636_abnormal_mineral_homeostasis | 0.87577942 |
| 123 | MP0004264_abnormal_extraembryonic_tissu | 0.87396181 |
| 124 | MP0008775_abnormal_heart_ventricle | 0.86881596 |
| 125 | MP0000604_amyloidosis | 0.86684380 |
| 126 | MP0010329_abnormal_lipoprotein_level | 0.86641373 |
| 127 | MP0000367_abnormal_coat/_hair | 0.86324358 |
| 128 | MP0003638_abnormal_response/metabolism_ | 0.85469868 |
| 129 | MP0001919_abnormal_reproductive_system | 0.84957582 |
| 130 | MP0000465_gastrointestinal_hemorrhage | 0.83299908 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.83296574 |
| 132 | MP0002736_abnormal_nociception_after | 0.82342554 |
| 133 | MP0005645_abnormal_hypothalamus_physiol | 0.82331541 |
| 134 | MP0000249_abnormal_blood_vessel | 0.82035173 |
| 135 | MP0005499_abnormal_olfactory_system | 0.81923293 |
| 136 | MP0005394_taste/olfaction_phenotype | 0.81923293 |
| 137 | MP0003075_altered_response_to | 0.81347102 |
| 138 | MP0002282_abnormal_trachea_morphology | 0.79138896 |
| 139 | MP0003880_abnormal_central_pattern | 0.78055600 |
| 140 | MP0008961_abnormal_basal_metabolism | 0.77665131 |
| 141 | MP0000647_abnormal_sebaceous_gland | 0.77642771 |
| 142 | MP0000383_abnormal_hair_follicle | 0.77471412 |
| 143 | MP0000569_abnormal_digit_pigmentation | 0.77110005 |
| 144 | MP0005166_decreased_susceptibility_to | 0.76889115 |
| 145 | MP0009115_abnormal_fat_cell | 0.75360413 |
| 146 | MP0009046_muscle_twitch | 0.75201194 |
| 147 | MP0005389_reproductive_system_phenotype | 0.75191155 |
| 148 | MP0003868_abnormal_feces_composition | 0.74282970 |
| 149 | MP0003806_abnormal_nucleotide_metabolis | 0.72062215 |
| 150 | MP0010386_abnormal_urinary_bladder | 0.71977946 |
| 151 | MP0000372_irregular_coat_pigmentation | 0.70930592 |
| 152 | MP0005167_abnormal_blood-brain_barrier | 0.69853819 |
| 153 | MP0005165_increased_susceptibility_to | 0.68682195 |
| 154 | MP0003186_abnormal_redox_activity | 0.67147533 |
| 155 | MP0005164_abnormal_response_to | 0.66860319 |
| 156 | MP0005319_abnormal_enzyme/_coenzyme | 0.66835719 |
| 157 | MP0004484_altered_response_of | 0.66453678 |
| 158 | MP0002168_other_aberrant_phenotype | 0.66174142 |
| 159 | MP0002971_abnormal_brown_adipose | 0.65927380 |
| 160 | MP0005646_abnormal_pituitary_gland | 0.65919239 |
| 161 | MP0009765_abnormal_xenobiotic_induced | 0.65501312 |
| 162 | MP0004185_abnormal_adipocyte_glucose | 0.64581425 |
| 163 | MP0009745_abnormal_behavioral_response | 0.64340306 |
| 164 | MP0005085_abnormal_gallbladder_physiolo | 0.63758248 |
| 165 | MP0004782_abnormal_surfactant_physiolog | 0.63052301 |
| 166 | MP0000631_abnormal_neuroendocrine_gland | 0.62868633 |
| 167 | MP0003252_abnormal_bile_duct | 0.62852327 |
| 168 | MP0002136_abnormal_kidney_physiology | 0.62472410 |
| 169 | MP0005390_skeleton_phenotype | 0.61952540 |
| 170 | MP0000598_abnormal_liver_morphology | 0.60690011 |
| 171 | MP0003786_premature_aging | 0.60098042 |
| 172 | MP0005334_abnormal_fat_pad | 0.59574669 |
| 173 | MP0001881_abnormal_mammary_gland | 0.58715304 |
| 174 | MP0003091_abnormal_cell_migration | 0.58425465 |
| 175 | MP0004142_abnormal_muscle_tone | 0.55590852 |
| 176 | MP0004147_increased_porphyrin_level | 0.55293300 |
| 177 | MP0004742_abnormal_vestibular_system | 0.52433772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oral leukoplakia (HP:0002745) | 7.65862834 |
| 2 | Chronic otitis media (HP:0000389) | 6.57443485 |
| 3 | Nasal polyposis (HP:0100582) | 5.50975067 |
| 4 | Abnormality of the nasal mucosa (HP:0000433) | 5.35635503 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.16801914 |
| 6 | Recurrent bronchitis (HP:0002837) | 4.91898687 |
| 7 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.87694350 |
| 8 | Absent/shortened dynein arms (HP:0200106) | 4.87262418 |
| 9 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.87262418 |
| 10 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.82943756 |
| 11 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.82943756 |
| 12 | Eczematoid dermatitis (HP:0000976) | 4.80340067 |
| 13 | Alopecia of scalp (HP:0002293) | 4.47508165 |
| 14 | Abnormality of T cell number (HP:0011839) | 4.44189178 |
| 15 | Abnormal ciliary motility (HP:0012262) | 4.42593842 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 4.40531494 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.40531494 |
| 18 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.37584498 |
| 19 | T lymphocytopenia (HP:0005403) | 4.36329528 |
| 20 | Myositis (HP:0100614) | 4.35001343 |
| 21 | Palmoplantar hyperkeratosis (HP:0000972) | 4.34014309 |
| 22 | Recurrent fungal infections (HP:0002841) | 4.30455627 |
| 23 | Abnormality of nail color (HP:0100643) | 4.24002322 |
| 24 | Palmar hyperkeratosis (HP:0010765) | 4.16876160 |
| 25 | Erythroderma (HP:0001019) | 4.14327919 |
| 26 | Lip pit (HP:0100267) | 4.09516887 |
| 27 | Rhinitis (HP:0012384) | 4.02676470 |
| 28 | Chronic bronchitis (HP:0004469) | 3.99461464 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.98355614 |
| 30 | Recurrent viral infections (HP:0004429) | 3.92354636 |
| 31 | Plantar hyperkeratosis (HP:0007556) | 3.86950831 |
| 32 | Chronic sinusitis (HP:0011109) | 3.80520339 |
| 33 | Recurrent abscess formation (HP:0002722) | 3.62587920 |
| 34 | Bronchiectasis (HP:0002110) | 3.60234519 |
| 35 | Abnormality of the axillary hair (HP:0100134) | 3.50994019 |
| 36 | Abnormality of secondary sexual hair (HP:0009888) | 3.50994019 |
| 37 | Orchitis (HP:0100796) | 3.50134810 |
| 38 | Recurrent skin infections (HP:0001581) | 3.47836832 |
| 39 | Pancreatic cysts (HP:0001737) | 3.46216117 |
| 40 | Abnormality of T cells (HP:0002843) | 3.39591003 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 3.36475919 |
| 42 | Spontaneous hematomas (HP:0007420) | 3.23695208 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.20832019 |
| 44 | Autoimmune hemolytic anemia (HP:0001890) | 3.18649544 |
| 45 | Increased IgM level (HP:0003496) | 3.18032247 |
| 46 | Stomatitis (HP:0010280) | 3.15046188 |
| 47 | Optic neuritis (HP:0100653) | 3.11192054 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 3.11192054 |
| 49 | Vasculitis (HP:0002633) | 3.10511911 |
| 50 | Fragile nails (HP:0001808) | 3.09531654 |
| 51 | Hypotrichosis (HP:0001006) | 3.09095242 |
| 52 | Gingival bleeding (HP:0000225) | 3.08409537 |
| 53 | Pancreatic fibrosis (HP:0100732) | 3.08407587 |
| 54 | True hermaphroditism (HP:0010459) | 3.07866395 |
| 55 | Chronic diarrhea (HP:0002028) | 3.07408049 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 3.06584617 |
| 57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.06579649 |
| 58 | Pustule (HP:0200039) | 3.05453374 |
| 59 | Furrowed tongue (HP:0000221) | 3.03864269 |
| 60 | Hemoptysis (HP:0002105) | 3.02102589 |
| 61 | Severe combined immunodeficiency (HP:0004430) | 3.00986444 |
| 62 | Joint swelling (HP:0001386) | 2.99920363 |
| 63 | Molar tooth sign on MRI (HP:0002419) | 2.98084088 |
| 64 | Abnormality of midbrain morphology (HP:0002418) | 2.98084088 |
| 65 | Corneal erosion (HP:0200020) | 2.95008916 |
| 66 | Sparse eyelashes (HP:0000653) | 2.92991517 |
| 67 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.92001681 |
| 68 | Abnormality of the fingertips (HP:0001211) | 2.90695046 |
| 69 | Arterial thrombosis (HP:0004420) | 2.88381556 |
| 70 | Combined immunodeficiency (HP:0005387) | 2.87788196 |
| 71 | Hypoplastic labia majora (HP:0000059) | 2.83542781 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.81225867 |
| 73 | Eosinophilia (HP:0001880) | 2.75263974 |
| 74 | Panhypogammaglobulinemia (HP:0003139) | 2.73223949 |
| 75 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.72001941 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.71591278 |
| 77 | Abnormality of eosinophils (HP:0001879) | 2.65497634 |
| 78 | Onycholysis (HP:0001806) | 2.63458990 |
| 79 | Myocardial infarction (HP:0001658) | 2.61923138 |
| 80 | Leukocytosis (HP:0001974) | 2.61215906 |
| 81 | Nephronophthisis (HP:0000090) | 2.60636127 |
| 82 | Abnormality of the renal cortex (HP:0011035) | 2.60290358 |
| 83 | Nail dystrophy (HP:0008404) | 2.57592651 |
| 84 | Abnormality of macrophages (HP:0004311) | 2.57433865 |
| 85 | Bronchitis (HP:0012387) | 2.57247537 |
| 86 | Abnormality of the labia majora (HP:0012881) | 2.57046864 |
| 87 | Systemic lupus erythematosus (HP:0002725) | 2.56425436 |
| 88 | Inflammation of the large intestine (HP:0002037) | 2.54859891 |
| 89 | Colitis (HP:0002583) | 2.52309404 |
| 90 | Meningitis (HP:0001287) | 2.51890345 |
| 91 | Pulmonary infiltrates (HP:0002113) | 2.51672590 |
| 92 | Abnormality of T cell physiology (HP:0011840) | 2.51346382 |
| 93 | Conical tooth (HP:0000698) | 2.51112972 |
| 94 | Gingivitis (HP:0000230) | 2.50881742 |
| 95 | IgG deficiency (HP:0004315) | 2.50673108 |
| 96 | Basal ganglia calcification (HP:0002135) | 2.50662082 |
| 97 | Increased IgE level (HP:0003212) | 2.47308779 |
| 98 | Cheilitis (HP:0100825) | 2.45139989 |
| 99 | Pulmonary embolism (HP:0002204) | 2.45088235 |
| 100 | Chronic hepatic failure (HP:0100626) | 2.44993153 |
| 101 | Thyroiditis (HP:0100646) | 2.44793318 |
| 102 | Epistaxis (HP:0000421) | 2.44039021 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 2.44007887 |
| 104 | Milia (HP:0001056) | 2.42681450 |
| 105 | Absent eyelashes (HP:0000561) | 2.41710367 |
| 106 | Parakeratosis (HP:0001036) | 2.41481578 |
| 107 | Hypoplasia of the thymus (HP:0000778) | 2.39893409 |
| 108 | Abnormality of B cell number (HP:0010975) | 2.38948204 |
| 109 | B lymphocytopenia (HP:0010976) | 2.38948204 |
| 110 | Keratoconjunctivitis (HP:0001096) | 2.37100151 |
| 111 | Emphysema (HP:0002097) | 2.36908909 |
| 112 | Sparse scalp hair (HP:0002209) | 2.36890111 |
| 113 | Abnormality of the renal medulla (HP:0100957) | 2.35851186 |
| 114 | Agammaglobulinemia (HP:0004432) | 2.35649796 |
| 115 | Granulocytopenia (HP:0001913) | 2.35356081 |
| 116 | Thrombocytosis (HP:0001894) | 2.34558486 |
| 117 | Ectropion (HP:0000656) | 2.32665275 |
| 118 | Woolly hair (HP:0002224) | 2.32247161 |
| 119 | Anorexia (HP:0002039) | 2.31340962 |
| 120 | Duplicated collecting system (HP:0000081) | 2.30684910 |
| 121 | Joint hemorrhage (HP:0005261) | 2.30247003 |
| 122 | Abnormality of the salivary glands (HP:0010286) | 2.29195791 |
| 123 | Medial flaring of the eyebrow (HP:0010747) | 2.28712987 |
| 124 | Periodontitis (HP:0000704) | 2.28410169 |
| 125 | Thick nail (HP:0001805) | 2.26505444 |
| 126 | Congenital stationary night blindness (HP:0007642) | 2.25708816 |
| 127 | Tubular atrophy (HP:0000092) | 2.25167367 |
| 128 | IgM deficiency (HP:0002850) | 2.24810314 |
| 129 | Keratoconjunctivitis sicca (HP:0001097) | 2.22802730 |
| 130 | Gastrointestinal infarctions (HP:0005244) | 2.22522954 |
| 131 | Chest pain (HP:0100749) | 2.20924117 |
| 132 | Oligodontia (HP:0000677) | 2.20774756 |
| 133 | Abnormality of the renal collecting system (HP:0004742) | 2.20679334 |
| 134 | Cystic liver disease (HP:0006706) | 2.20544472 |
| 135 | Popliteal pterygium (HP:0009756) | 2.20354122 |
| 136 | Prolonged bleeding time (HP:0003010) | 2.20216032 |
| 137 | Fair hair (HP:0002286) | 2.18815615 |
| 138 | Abnormal hair laboratory examination (HP:0003328) | 2.18573984 |
| 139 | Hematochezia (HP:0002573) | 2.18125748 |
| 140 | Cellulitis (HP:0100658) | 2.15724299 |
| 141 | Lymphopenia (HP:0001888) | 2.13290970 |
| 142 | Decreased circulating renin level (HP:0003351) | 2.13158316 |
| 143 | Recurrent sinusitis (HP:0011108) | 2.12615452 |
| 144 | Porencephaly (HP:0002132) | 2.12391021 |
| 145 | Hyperactive renin-angiotensin system (HP:0000841) | 2.11590796 |
| 146 | Esophageal varix (HP:0002040) | 2.09812937 |
| 147 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.08888603 |
| 148 | Thrombophlebitis (HP:0004418) | 2.08531956 |
| 149 | IgA deficiency (HP:0002720) | 2.08354443 |
| 150 | Encephalitis (HP:0002383) | 2.05122209 |
| 151 | Gangrene (HP:0100758) | 2.04748882 |
| 152 | Erythema (HP:0010783) | 2.04698738 |
| 153 | Skin ulcer (HP:0200042) | 2.02688439 |
| 154 | Absent hair (HP:0002298) | 2.01708534 |
| 155 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.01638651 |
| 156 | Type II lissencephaly (HP:0007260) | 2.00938090 |
| 157 | Congenital, generalized hypertrichosis (HP:0004540) | 1.98428680 |
| 158 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.97667606 |
| 159 | Labial hypoplasia (HP:0000066) | 1.97207311 |
| 160 | Purpura (HP:0000979) | 1.96377785 |
| 161 | Chronic obstructive pulmonary disease (HP:0006510) | 1.95972131 |
| 162 | Obstructive lung disease (HP:0006536) | 1.95972131 |
| 163 | Complement deficiency (HP:0004431) | 1.95227873 |
| 164 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.94055003 |
| 165 | Mesangial abnormality (HP:0001966) | 1.92766937 |
| 166 | Abnormality of the endocardium (HP:0004306) | 1.89166823 |
| 167 | Pili torti (HP:0003777) | 1.88533531 |
| 168 | Tetraparesis (HP:0002273) | 1.87906654 |
| 169 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.87456797 |
| 170 | Right ventricular cardiomyopathy (HP:0011663) | 1.87092522 |
| 171 | Hypohidrosis (HP:0000966) | 1.86944181 |
| 172 | Depressed nasal tip (HP:0000437) | 1.86874989 |
| 173 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.85185454 |
| 174 | Portal hypertension (HP:0001409) | 1.84037664 |
| 175 | Urticaria (HP:0001025) | 1.83700172 |
| 176 | Stomach cancer (HP:0012126) | 1.81202924 |
| 177 | Blepharitis (HP:0000498) | 1.80780710 |
| 178 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.79772850 |
| 179 | Recurrent corneal erosions (HP:0000495) | 1.78959879 |
| 180 | Congenital hepatic fibrosis (HP:0002612) | 1.78610548 |
| 181 | Abnormal drinking behavior (HP:0030082) | 1.78022530 |
| 182 | Polydipsia (HP:0001959) | 1.78022530 |
| 183 | Brittle hair (HP:0002299) | 1.76998310 |
| 184 | Asplenia (HP:0001746) | 1.76965543 |
| 185 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.74152414 |
| 186 | Generalized hypopigmentation of hair (HP:0011358) | 1.73676599 |
| 187 | Palmoplantar keratoderma (HP:0000982) | 1.73395116 |
| 188 | Renal cortical cysts (HP:0000803) | 1.70857597 |
| 189 | Abolished electroretinogram (ERG) (HP:0000550) | 1.70347887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 4.94802114 |
| 2 | TYK2 | 4.77887124 |
| 3 | MAPKAPK3 | 4.41304890 |
| 4 | FRK | 4.32038774 |
| 5 | JAK3 | 3.70932118 |
| 6 | TXK | 3.62709815 |
| 7 | IKBKE | 3.54612766 |
| 8 | BMPR1B | 3.46000471 |
| 9 | JAK1 | 3.44634812 |
| 10 | MAP4K1 | 3.26198923 |
| 11 | FGFR3 | 2.93545763 |
| 12 | MAP3K14 | 2.80080482 |
| 13 | KIT | 2.78669568 |
| 14 | ADRBK2 | 2.73462625 |
| 15 | TBK1 | 2.67627311 |
| 16 | MAP3K6 | 2.56921535 |
| 17 | TLK1 | 2.50923519 |
| 18 | EPHA2 | 2.35406465 |
| 19 | GRK1 | 2.32337234 |
| 20 | ERBB3 | 2.24680412 |
| 21 | MAP4K2 | 2.14594436 |
| 22 | WNK4 | 2.13449943 |
| 23 | ZAP70 | 2.07307115 |
| 24 | STK24 | 1.90445995 |
| 25 | EPHA3 | 1.83402628 |
| 26 | PINK1 | 1.79500754 |
| 27 | BCR | 1.78702245 |
| 28 | MAP3K2 | 1.77473216 |
| 29 | EPHB1 | 1.75959024 |
| 30 | MAPK15 | 1.75039859 |
| 31 | ERN1 | 1.68539942 |
| 32 | ZAK | 1.67767337 |
| 33 | TNIK | 1.63551987 |
| 34 | MAP2K6 | 1.61472599 |
| 35 | FER | 1.56424911 |
| 36 | ITK | 1.55271074 |
| 37 | STK39 | 1.53200057 |
| 38 | NME1 | 1.51177218 |
| 39 | TGFBR2 | 1.48798706 |
| 40 | MAPK13 | 1.47939871 |
| 41 | IRAK4 | 1.47529457 |
| 42 | NLK | 1.45824476 |
| 43 | SIK1 | 1.43206363 |
| 44 | TRPM7 | 1.42097072 |
| 45 | BLK | 1.41316758 |
| 46 | WNK3 | 1.40949918 |
| 47 | MAP3K13 | 1.39872979 |
| 48 | IKBKB | 1.37129390 |
| 49 | LCK | 1.36626247 |
| 50 | CSK | 1.35675873 |
| 51 | TEC | 1.34703716 |
| 52 | MAP3K3 | 1.34201429 |
| 53 | ACVR1B | 1.31563492 |
| 54 | IRAK3 | 1.25130365 |
| 55 | MUSK | 1.24540996 |
| 56 | JAK2 | 1.22477217 |
| 57 | RIPK1 | 1.17819831 |
| 58 | INSRR | 1.15240340 |
| 59 | STK10 | 1.13444823 |
| 60 | HCK | 1.12435040 |
| 61 | TRIM28 | 1.09400118 |
| 62 | MAPK11 | 1.07431465 |
| 63 | SYK | 1.05348643 |
| 64 | TGFBR1 | 1.04058470 |
| 65 | MARK3 | 1.03294220 |
| 66 | CHUK | 1.02161837 |
| 67 | BTK | 1.01913711 |
| 68 | ADRBK1 | 1.01773242 |
| 69 | PRKCI | 1.01654027 |
| 70 | TIE1 | 1.00711246 |
| 71 | CCNB1 | 1.00250647 |
| 72 | CSF1R | 0.97043132 |
| 73 | IRAK1 | 0.93732620 |
| 74 | MAP3K4 | 0.93600297 |
| 75 | CAMKK2 | 0.92001196 |
| 76 | RPS6KB2 | 0.89003142 |
| 77 | PAK3 | 0.88831542 |
| 78 | OXSR1 | 0.88605955 |
| 79 | PRKCE | 0.86910564 |
| 80 | NEK9 | 0.86749148 |
| 81 | PKN2 | 0.84409006 |
| 82 | KDR | 0.84310263 |
| 83 | CAMK1D | 0.78453818 |
| 84 | FLT3 | 0.76243232 |
| 85 | SIK3 | 0.76031310 |
| 86 | TTN | 0.73631043 |
| 87 | PRKCH | 0.70755966 |
| 88 | TAOK3 | 0.69109435 |
| 89 | NME2 | 0.68533884 |
| 90 | MAP3K7 | 0.67646710 |
| 91 | FES | 0.67461980 |
| 92 | PDGFRB | 0.66978064 |
| 93 | CAMK1G | 0.66931016 |
| 94 | PRKCQ | 0.65673360 |
| 95 | PIM1 | 0.64654734 |
| 96 | LYN | 0.64461635 |
| 97 | PTK2B | 0.64387879 |
| 98 | RIPK4 | 0.63811336 |
| 99 | SIK2 | 0.63686731 |
| 100 | EIF2AK2 | 0.62367618 |
| 101 | CSNK1G2 | 0.60925207 |
| 102 | BMX | 0.60835373 |
| 103 | SGK3 | 0.59341944 |
| 104 | GRK6 | 0.58657470 |
| 105 | CSNK1G1 | 0.57038555 |
| 106 | MAP2K2 | 0.56039584 |
| 107 | CSNK1G3 | 0.55764238 |
| 108 | NUAK1 | 0.54749986 |
| 109 | STK38L | 0.53495072 |
| 110 | TRIB3 | 0.52091476 |
| 111 | MATK | 0.50505579 |
| 112 | STK3 | 0.50261846 |
| 113 | OBSCN | 0.48876287 |
| 114 | EGFR | 0.46551398 |
| 115 | TNK2 | 0.46010437 |
| 116 | RPS6KA5 | 0.44989616 |
| 117 | PTK6 | 0.43494395 |
| 118 | IGF1R | 0.42963516 |
| 119 | LRRK2 | 0.42687105 |
| 120 | MST4 | 0.42023241 |
| 121 | PDK1 | 0.41709592 |
| 122 | MAPKAPK5 | 0.40622187 |
| 123 | EEF2K | 0.38796623 |
| 124 | CDK8 | 0.38323184 |
| 125 | MAP3K12 | 0.37357014 |
| 126 | CSNK1A1L | 0.36321559 |
| 127 | CASK | 0.36084772 |
| 128 | PIK3CA | 0.34492964 |
| 129 | HIPK2 | 0.34217973 |
| 130 | MAP3K10 | 0.33473091 |
| 131 | MAP2K7 | 0.33266720 |
| 132 | RPS6KA4 | 0.32590150 |
| 133 | DAPK2 | 0.32497854 |
| 134 | MAP2K3 | 0.31704940 |
| 135 | ABL1 | 0.31665779 |
| 136 | MAPK4 | 0.31374682 |
| 137 | FGR | 0.31354225 |
| 138 | NEK6 | 0.30762286 |
| 139 | PRKAA2 | 0.28646163 |
| 140 | PRKCA | 0.28187385 |
| 141 | MST1R | 0.27843422 |
| 142 | PRKCG | 0.27815260 |
| 143 | RET | 0.27319066 |
| 144 | PIM2 | 0.27305771 |
| 145 | INSR | 0.26641987 |
| 146 | VRK2 | 0.26321820 |
| 147 | PHKG1 | 0.25879934 |
| 148 | PHKG2 | 0.25879934 |
| 149 | VRK1 | 0.25431740 |
| 150 | DMPK | 0.25256597 |
| 151 | WNK1 | 0.24634589 |
| 152 | PRKCD | 0.24582791 |
| 153 | MAP2K1 | 0.24578647 |
| 154 | CSNK1A1 | 0.24278252 |
| 155 | PRKACA | 0.23490687 |
| 156 | PDGFRA | 0.23375106 |
| 157 | MAPK3 | 0.22829773 |
| 158 | CDK4 | 0.21573353 |
| 159 | FYN | 0.21151912 |
| 160 | MAP3K1 | 0.20805130 |
| 161 | PBK | 0.20692789 |
| 162 | CDK12 | 0.18130621 |
| 163 | SRC | 0.16722374 |
| 164 | GRK7 | 0.16400287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.68637966 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 3.40223486 |
| 3 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.20276773 |
| 4 | Measles_Homo sapiens_hsa05162 | 3.11301192 |
| 5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.01115287 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.83598540 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.82154185 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.79275570 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.78487691 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.62860619 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.62728471 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.56006362 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.43414126 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.42708379 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.39564758 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.39052953 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.36475279 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.36067811 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 2.32663596 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.25344894 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.24770651 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.22002297 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12408625 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.09764844 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 2.07572029 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06641530 |
| 27 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.02033028 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.01271497 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00446770 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.97001552 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.94519657 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.87104699 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73363592 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72886008 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.71527956 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.71493295 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.70934261 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.70290163 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68893218 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.67129490 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.63943339 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.60216204 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59330627 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.54350090 |
| 45 | Protein export_Homo sapiens_hsa03060 | 1.51093673 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48334727 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45480707 |
| 48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.44356104 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41720392 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38928422 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.38819962 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34319047 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 1.34037360 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.30958540 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28043208 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 1.27916409 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27001653 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 1.25023645 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21642937 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.21145458 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.20209261 |
| 62 | Olfactory transduction_Homo sapiens_hsa04740 | 1.18455470 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 1.18100964 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14404495 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.10395175 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09466475 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.09047885 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.07953672 |
| 69 | Apoptosis_Homo sapiens_hsa04210 | 1.06253803 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 1.06243818 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05823012 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 1.03156957 |
| 73 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.01092212 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99818296 |
| 75 | Nicotine addiction_Homo sapiens_hsa05033 | 0.98997220 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98581507 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96757197 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96083198 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.95222115 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94985548 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94184074 |
| 82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93961550 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92183208 |
| 84 | Asthma_Homo sapiens_hsa05310 | 0.92164926 |
| 85 | Salivary secretion_Homo sapiens_hsa04970 | 0.90749177 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90416550 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89573751 |
| 88 | Homologous recombination_Homo sapiens_hsa03440 | 0.85804556 |
| 89 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.84152463 |
| 90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82335930 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.81314436 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80468816 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78219322 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.78198247 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.77012105 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76979091 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76052564 |
| 98 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.72606746 |
| 99 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69760104 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69180717 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.67671269 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66853205 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.66729513 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66708927 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66457623 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | 0.64364708 |
| 107 | RNA polymerase_Homo sapiens_hsa03020 | 0.64354162 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63906882 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.62867474 |
| 110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62081753 |
| 111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61205154 |
| 112 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.60221731 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59714890 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58890950 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58249979 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57946814 |
| 117 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.57896887 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57703210 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56131681 |
| 120 | Renin secretion_Homo sapiens_hsa04924 | 0.54809369 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54304059 |
| 122 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54176068 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54121571 |
| 124 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53576402 |
| 125 | RNA degradation_Homo sapiens_hsa03018 | 0.51658057 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51648264 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50704086 |
| 128 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49508998 |
| 129 | Peroxisome_Homo sapiens_hsa04146 | 0.48556361 |
| 130 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46950780 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46912681 |
| 132 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46794384 |
| 133 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46496147 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46191842 |
| 135 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45975445 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.45792153 |
| 137 | Proteasome_Homo sapiens_hsa03050 | 0.44609428 |
| 138 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44326161 |
| 139 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.43991016 |
| 140 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41523208 |
| 141 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39836075 |
| 142 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39280992 |
| 143 | Circadian entrainment_Homo sapiens_hsa04713 | 0.38989987 |
| 144 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37849515 |
| 145 | Lysosome_Homo sapiens_hsa04142 | 0.36974300 |
| 146 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36499210 |
| 147 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35560983 |
| 148 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31376872 |
| 149 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.30735808 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.29885338 |
| 151 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.29337817 |
| 152 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29042702 |
| 153 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26619267 |
| 154 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.26123887 |
| 155 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25601243 |
| 156 | Prion diseases_Homo sapiens_hsa05020 | 0.23917160 |
| 157 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23763528 |
| 158 | Other glycan degradation_Homo sapiens_hsa00511 | 0.22556143 |
| 159 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22289306 |
| 160 | Phagosome_Homo sapiens_hsa04145 | 0.21652109 |
| 161 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.21493083 |
| 162 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21428627 |
| 163 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20006631 |
| 164 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.18258013 |
| 165 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17253103 |
| 166 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.15786979 |

